Players in the Global Premenstrual Syndrome (Pms) Market Eyeing the Lucrative Markets of Asia Pacific and Row

Submitted by: Submitted by

Views: 10

Words: 566

Pages: 3

Category: Business and Industry

Date Submitted: 08/17/2015 04:19 AM

Report This Essay

The global premenstrual syndrome (PMS) market is segmented by treatment into supplements and alternative treatments (non-prescribed). Many women have found these methods helpful. Often, doctors prescribe combination therapies to treat PMS. Some of the therapies used for treating premenstrual syndrome include diet, exercise, supplements, psychological therapy, and other medical treatment.

Medical Treatment to Treat PMS

The medical treatment sector in the global premenstrual syndrome (PMS) market holds a significant share. On the basis of treatment, the medical treatment sector in the global PMS market is divided into painkillers, oral contraceptive pills, estrogen-only patches and implants, gonadotropin-releasing hormone (GnRH) analogues, and selective serotonin reuptake inhibitors (SSRIs).

The common painkillers available in the global premenstrual syndrome (PMS) market to treat PMS include paracetamol and NSAIDs. Many painkillers are available over the counter in the global premenstrual syndrome (PMS) market. SSRIs are prescribed for patients that suffer from severe PMS or premenstrual dysphoric disorder (PMDD). SSRIs such as sertraline and fluoxetine are antidepressants used to combat depression and relieve tiredness due to PMS. On the other hand, GnRH are synthetic hormones that result in a temporary menopause and are taken as an injection. GnRH is prescribed for patients that have severe PMS. The rising demand for hormone therapy-based treatment worldwide has contributed to the rise in sales of the overall global premenstrual syndrome (PMS) market by a great extent.

New Drugs for PMS in Pipeline

Several drugs aimed at treating premenstrual syndrome are in the pipeline. By stages, the global premenstrual syndrome (PMS) market’s pipeline is segmented into pre-registration phase, clinical phase, pre-clinical phase, and discovery phase. Some of the drugs in the global premenstrual syndrome (PMS) market pipeline are Dutasteride, ProgestoMat,...